
Auteur C. MONTGOMERY
|
Documents disponibles écrits par cet auteur (10)

H. R. SUMNALL ; A. ATKINSON ; C. MONTGOMERY ; O. MAYNARD ; J. NICHOLLS | 2023
Dans International Journal of Drug Policy (Vol.111, January 2023) Article : PériodiqueBackground: Drug related deaths (DRD) are at historically high levels in the United Kingdom (UK), but some approaches that have the potential to reduce risk of mortality remain controversial. Public support makes an important contribution to dru[...]
ENGLISH : Random letter generation and computation span are tasks known to load on executive, prefrontal resources. Previous research suggests that Ecstasy users are impaired on random letter generation. The current study, employing a larger s[...]
H. SUMNALL ; A. ATKINSON ; S. GAGE ; I. HAMILTON ; C. MONTGOMERY | 2021
Dans Health Education (Vol.121, n°6, December 2021) Article : PériodiquePurpose: Stigma reduction is an important public health challenge because of the large morbidity and mortality associated with some forms of substance use. Extreme stigma can lead to dehumanisation of target groups, who are ascribed with lesser [...]
J. E. FISK ; P. N. MURPHY ; C. MONTGOMERY ; F. HADJIEFTHYVOULOU | 2011
Dans Addiction (Vol.106, n°4, April 2011) Article : PériodiqueAIMS Ecstasy, the street name for 3,4-meththylenedioxymethamphetamine, has been associated with a range of psychiatric symptoms and impaired psychological health in both problem and recreational users. The purpose of the present paper is to dete[...]
H. R. SUMNALL ; C. MONTGOMERY ; A. M. ATKINSON ; S. H. GAGE ; I. D. BOARDLEY | 2022
Dans Drugs: Education, Prevention and Policy (Vol.29, n°5, October 2022) Article : PériodiqueThere has been recent UK media attention on the global impact of the cocaine trade and the morality of personal use of cocaine powder. In this study we investigated whether people who use cocaine engage in moral disengagement (MD) strategies to [...]
J. E. FISK ; C. MONTGOMERY ; M. WAREING ; P. N. MURPHY | 2006
Dans Human Psychopharmacology: Clinical and Experimental (Vol.21, n°6, August 2006) Article : PériodiqueThe research evidence regarding the potential effects of ecstasy suggests that it may be neurotoxic and that its use is associated with cognitive impairment. In recent years evidence has emerged suggesting that cannabinoids, the active ingredien[...]
C. MONTGOMERY ; J. E. FISK ; R. NEWCOMBE | 2005
Dans Psychopharmacology (Vol.180, n°1, June 2005) Article : PériodiqueRATIONALE/OBJECTIVES: Research has revealed associative learning deficits among users of ecstasy; the present study explored the component processes underlying these deficits. METHODS: Thirty-five ecstasy users and 62 non-ecstasy users completed[...]
M. WAREING ; J. E. FISK ; P. MURPHY ; C. MONTGOMERY | 2004
Dans Human Psychopharmacology: Clinical and Experimental (Vol.19, n°4, June 2004) Article : PériodiquePrevious research suggests that MDMA users are impaired in various aspects of cognitive functioning, however, it remains unclear whether they might experience deficits in established measures of verbal working memory functioning. In the present [...]
M. WAREING ; J. E. FISK ; P. MURPHY ; C. MONTGOMERY | 2005
Dans Human Psychopharmacology: Clinical and Experimental (Vol.20, n°2, March 2005) Article : PériodiqueVerbal working memory and executive deficits have been observed in ecstasy users. The present study sought to establish whether these also extended to visuo-spatial working memory. Thirty-six current ecstasy users, 12 former users (abstinent for[...]Nouveauté
H. R. SUMNALL ; A. HOLLAND ; A. M. ATKINSON ; C. MONTGOMERY ; J. NICHOLLS ; O. M. MAYNARD | 2025
Dans International Journal of Drug Policy (Vol.136, February 2025) Article : PériodiqueBackground: News media is an important determinant of public understanding of drug policy topics. Recent media reporting around the use of synthetic drugs such as xylazine makes frequent use of non-human metaphors, including reference to the eff[...]